Geode Capital Management’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9K | Buy |
|
|||||
|
2025
Q1 | $8.67K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $13.1K | Hold |
|
|||||
|
2023
Q4 | $15.9K | Hold |
|
|||||
|
2023
Q3 | $16.4K | Buy |
|
|||||
|
2023
Q2 | $24.6K | Hold |
|
|||||
|
2023
Q1 | $31.7K | Hold |
|
|||||
|
2022
Q4 | $25K | Hold |
|
|||||
|
2022
Q3 | $80K | Hold |
|
|||||
|
2022
Q2 | $86K | Buy |
|
|||||
|
2022
Q1 | $155K | Hold |
|
|||||
|
2021
Q4 | $193K | Buy |
|
|||||
|
2021
Q3 | $363K | Buy |
|
|||||
|
2021
Q2 | $293K | Buy |
|
|||||
|
2021
Q1 | $182K | Buy |
|
|||||
|
2020
Q4 | $16K | Hold |
|
|||||
|
2020
Q3 | $15K | Hold |
|
|||||
|
2020
Q2 | $24K | Hold |
|
|||||
|
2020
Q1 | $12K | Hold |
|
|||||
|
2019
Q4 | $69K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $97K | Buy |
|
|||||
|
2019
Q1 | $21K | Hold |
|
|||||
|
2018
Q4 | $18K | Hold |
|
|||||
|
2018
Q3 | $26K | Hold |
|
|||||
|
2018
Q2 | $53K | Hold |
|
|||||
|
2018
Q1 | $284K | Hold |
|
|||||
|
2017
Q4 | $198K | Hold |
|
|||||
|
2017
Q3 | $203K | Hold |
|
|||||
|
2017
Q2 | $230K | Hold |
|
|||||
|
2017
Q1 | $356K | Hold |
|
|||||
|
2016
Q4 | $403K | Hold |
|
|||||
|
2016
Q3 | $876K | Hold |
|
|||||
|
2016
Q2 | $739K | Hold |
|
|||||
|
2016
Q1 | $710 | Hold |
|
|||||
|
2015
Q4 | $807K | Hold |
|
|||||
|
2015
Q3 | $771K | Hold |
|
|||||
|
2015
Q2 | $1.06M | Buy |
|